Li X-D, Li X-M, Gu J-W, Sun X-C
Dental Department, Yan'an People's Hospital of Shaanxi Province, Yan'an, Shaanxi, China.
Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7577. doi: 10.26355/eurrev_202007_22251.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway, by X.-D. Li, X.-M. Li, J.-W. Gu, X.-C. Sun, published in Eur Rev Med Pharmacol Sci 2017; 21 (22): 5153-5159-DOI: 10.26355/eurrev_201711_13832-PMID: 29228427" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/13832.
由于本文被怀疑存在研究不当行为,且通讯作者未回应我们要求证明数据和图表原创性的请求,“X.-D. Li、X.-M. Li、J.-W. Gu、X.-C. Sun发表于《欧洲医学与药理学评论》2017年;21(22):5153 - 5159 - DOI: 10.26355/eurrev_201711_13832 - PMID: 29228427的《MiR - 155通过靶向SOCS3/JAK - STAT3信号通路调节淋巴瘤细胞增殖和凋亡》”已被撤回。出版方对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/13832